Sleep Apnea Diagnostic Systems Market: By Diagnostic Type, Respiratory Polygraph, Single-Channel Screening Devices ), By End User And By Geography
Sleep Apnea Diagnostic Systems Market size was valued at US$ 299.4 million in 2022 and is poised to grow at a CAGR of 7.1% from 2023 to 2029. Sleep apnea is a genuine rest issue that happens when a man's breathing is hindered amid rest. Individuals with untreated rest apnea quit breathing over and over amid their rest, in some cases several times. This implies the mind - and whatever remains of the body - may not get enough oxygen. The increasing number of rehabilitation centers, and awareness campaigns to assist patients with neurological disorders has led to a rise in the number of patients seeking treatments for neurological disorders. The risk of sleep apnea is greater in the age group of 50-60 years. According to UNO estimations in 2012, the geriatric population was about 810Mn and it is anticipated to grow to over 2000Mn people by 2050 globally. Expanded spotlight on R&D exercises for creating inventive items and key activities, for example, merger and securing and new item dispatch is the significant system embraced by these players to keep up their market position. For example, In May 2017, Philips consented to secure arrangements with Respiratory Technologies, Inc. The obtaining will grow Philip's sleep and respiratory care business.
Study Period
2024-2030Base Year
2023CAGR
7.1%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Factors such as increase in the prevalence of sleep apnea globally is majorly driving the growth of the market. As per to the National Commission on Sleeping Disorders Research, globally about 38,000 deaths are occurring annually owing to the cardiovascular problems associated with sleepapnea. Furthermore, growing geriatric population, rising lifestyle changes, growing homecare acceptance, growing awareness about health, sleep disorders, improving healthcare infrastructure, introduction of new technologies and innovative products are the few factors which are boosting the growth of the market. However, strict regulatory procedures, side effects associated with the drugs, high competition in the market are the factors which are hampering the sleep apnea diagnostic systems growth.
Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population pool suffering with diabetic retinopathy. Owing to improved infrastructure and awareness among the people especially of emerging markets like China, India and Brazil, there is strong emphasis on the quality of life (QALY) for diabetic patients demanding early detection and treatment of chronic, the market seems to be agile and open.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 299.4 million |
|
Market CAGR |
7.1% |
|
By Diagnostic Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The sleep apnea diagnostic systems market size was valued at US$ 299.4 million in 2022
The sleep apnea diagnostic systems market key players are Koninklijke Philips (Netherlands) ResMed (US) Fisher & Paykel Healthcare (New Zealand) SomnoMed (Australia) Compumedics (Australia) Whole You (US) Drive DeVilbiss Healthcare (US)
The sleep apnea diagnostic systems market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Sleep Apnea Diagnostic Systems Market Introduction |
| 2.1.Global Sleep Apnea Diagnostic Systems Market - Taxonomy |
| 2.2.Global Sleep Apnea Diagnostic Systems Market - Definitions |
| 2.2.1. By Diagnostic Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3.Global Sleep Apnea Diagnostic Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Sleep Apnea Diagnostic Systems Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Sleep Apnea Diagnostic Systems Market By Diagnostic Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Actigraphy System |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Polysomnography Device (PSG) |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Respiratory Polygraph |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Single-Channel Screening Devices (Pulse Oximeter ) |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Sleep Apnea Diagnostic Systems Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Sleep Laboratories |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Home Care/Individuals |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Sleep Apnea Diagnostic Systems Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Diagnostic Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Actigraphy System |
| 8.1.2.Polysomnography Device (PSG) |
| 8.1.3.Respiratory Polygraph |
| 8.1.4.Single-Channel Screening Devices (Pulse Oximeter ) |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Sleep Laboratories |
| 8.2.2.Hospitals |
| 8.2.3.Home Care/Individuals |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Diagnostic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Actigraphy System |
| 9.1.2.Polysomnography Device (PSG) |
| 9.1.3.Respiratory Polygraph |
| 9.1.4.Single-Channel Screening Devices (Pulse Oximeter ) |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Sleep Laboratories |
| 9.2.2.Hospitals |
| 9.2.3.Home Care/Individuals |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Diagnostic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Actigraphy System |
| 10.1.2.Polysomnography Device (PSG) |
| 10.1.3.Respiratory Polygraph |
| 10.1.4.Single-Channel Screening Devices (Pulse Oximeter ) |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Sleep Laboratories |
| 10.2.2.Hospitals |
| 10.2.3.Home Care/Individuals |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Diagnostic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Actigraphy System |
| 11.1.2.Polysomnography Device (PSG) |
| 11.1.3.Respiratory Polygraph |
| 11.1.4.Single-Channel Screening Devices (Pulse Oximeter ) |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Sleep Laboratories |
| 11.2.2.Hospitals |
| 11.2.3.Home Care/Individuals |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Diagnostic Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Actigraphy System |
| 12.1.2.Polysomnography Device (PSG) |
| 12.1.3.Respiratory Polygraph |
| 12.1.4.Single-Channel Screening Devices (Pulse Oximeter ) |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Sleep Laboratories |
| 12.2.2.Hospitals |
| 12.2.3.Home Care/Individuals |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Koninklijke Philips (Netherlands) |
| 13.2.2.ResMed (US) |
| 13.2.3.Fisher & Paykel Healthcare (New Zealand) |
| 13.2.4.SomnoMed (Australia) |
| 13.2.5.Compumedics (Australia) |
| 13.2.6.Whole You (US) |
| 13.2.7.BMC Medical (China) |
| 13.2.8.Braebon Medical (Canada) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
